The Alendronic Acid Market has seen considerable growth due to its effectiveness in treating osteoporosis and related bone disorders. As a leading bisphosphonate, alendronic acid is primarily used to prevent bone loss, particularly in postmenopausal women and those with corticosteroid-induced osteoporosis. The market is driven by an aging global population, increased awareness of bone health,...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian